Nishio Tomohisa, Kurabe Nobuya, Goto-Inoue Naoko, Nakamura Toshio, Sugimura Haruhiko, Setou Mitsutoshi, Maekawa Masato
Department of Laboratory Medicine, Hamamatsu University School of Medicine, 1-20-1, Handayama, Higashi-ku, Hamamatsu 431-3192, Japan; Department of Cell Biology and Anatomy, Hamamatsu University School of Medicine, 1-20-1, Handayama, Higashi-ku, Hamamatsu 431-3192, Japan; Tsukuba Research Institute, Sekisui Medical Co., Ltd., 3-3-1, Kouyoudai, Ryugasaki 301-0852, Japan.
Department of Tumor Pathology, Hamamatsu University School of Medicine, 1-20-1, Handayama, Higashi-ku, Hamamatsu 431-3192, Japan.
Clin Chim Acta. 2017 Aug;471:276-282. doi: 10.1016/j.cca.2017.06.011. Epub 2017 Jun 13.
Colorectal cancer (CRC) is the fourth most frequent cause of cancer deaths in the world. Novel biomarkers for the diagnosis, prognosis, and treatment of CRC are required to improve the clinical strategy.
We applied shotgun proteomics using isobaric tags for relative and absolute quantitation (iTRAQ) to identify novel biomarkers of CRC, and then we detected leucine-rich PPR-motif-containing protein (LRPPRC) expression in 83 normal colorectal tissues and 133 CRC tissues by immunohistochemistry.
A total of 570 proteins were identified using iTRAQ. We validated the expression of LRPPRC protein by immunohistochemical analysis of the 77 proteins that showed expression changes in the cancer tissues >1.5-fold the levels in the normal tissues. The expression levels of LRPPRC were significantly higher in CRC tissues than those in normal colorectal tissues, and the expression levels were related with tumor differentiation and especially high in moderately differentiated CRC tissues.
We identified a novel, differentially expressed protein, LRPPRC, which has the potential to serve as a molecular target for diagnosis and/or prognosis of CRC.
结直肠癌(CRC)是全球第四大常见癌症死因。需要新的生物标志物用于CRC的诊断、预后评估和治疗,以改善临床策略。
我们应用基于等压标签相对和绝对定量(iTRAQ)的鸟枪法蛋白质组学来鉴定CRC的新型生物标志物,然后通过免疫组织化学检测83例正常结直肠组织和133例CRC组织中富含亮氨酸的PPR基序蛋白(LRPPRC)的表达。
使用iTRAQ共鉴定出570种蛋白质。我们通过免疫组织化学分析验证了77种在癌组织中表达变化>正常组织水平1.5倍的蛋白质中LRPPRC蛋白的表达。CRC组织中LRPPRC的表达水平显著高于正常结直肠组织,且表达水平与肿瘤分化相关,在中度分化的CRC组织中尤其高。
我们鉴定出一种新型的差异表达蛋白LRPPRC,它有潜力作为CRC诊断和/或预后的分子靶点。